Request an Invitation
CardioExchange has 4,577 members
FDA Approves Mipomersen for Homozygous Familial Hypercholesterolemia
The FDA said today that it had granted approval to the novel cholesterol-lowering drug mipomersen sodium for use as an adjunct to diet and drug therap...
To continue reading, please log in to the right or
request an invitation
Member Sign In
Stay Signed In
Forgot your password?
Request an invitation
to become a CardioExchange member.
Copyrighted © 2013, Massachusetts Medical Society
The content of this site is intended for health care professionals.